MGI, a subsidiary of BGI group, concluded a fruitful Technology and Application Conference of Genomics (TACG) at ICG-13 on October 25. Ideas and inspirations were shared by the leading academics and business insiders at TACG, topics covering NGS technology and genomics applications. Prof. Yang Huanming, Chairman of BGI Group made the opening remarks. He mentioned that the life science tools that MGI provides are extremely important for the study of genomics. Among other inspiring speakers, Dr....

SHENZHEN, China (October 25, 2018) – MGI, a subsidiary of BGI Group, introduced its newest model of genetic sequencer, MGISEQ-T7, which vastly improves speed, throughput and flexibility, at the 13th International Conference on Genomics (ICG-13) in Shenzhen. The most powerful MGI sequencer to date, MGISEQ-T7 is built with innovative quadruple flowcell staging that allows simultaneous but independent operation of 1 to 4 flowcells in a single run. The MGI proprietary technology used in T7 delivers...

Besides genetic sequencers, various library preparation products have become more and more available and play an essential role in advancing the development of sequencing. MGI, a subsidiary of BGI Group, the world’s leading genomics organization, has been developing a variety of library preparation kits too, along with its own sequencing platforms. As one of MGI RNA libraries preparation series, MGIEasy RNA Library Prep Set provides an efficient solution for generating libraries from a wide ra...

MGISEQ-2000 Timeline: ● 2017 October 27: ICG-12 Debuts ● 2018 February 14: Successive delivery to BGI Genomics, Gene+, WeGene and Riken Japan, etc al. ● 2018 Summer: There goes PE150 for MGISEQ-2000! About PE150 sequencing: > Average running time: 3 days > Average effective reads per Flow Cell: up to 1500M > 4 lanes per Flow Cell > Average effective reads per lane: at least 350M > Maximal sequencing cycles: 320 Now open for order! Data speak for themselves: Stable Performance Sam...

MGI is pleased to announce the appointment of Decode Science as the distributor for the MGI range of next generation sequencers and related products in Australia and New Zealand regions. This partnership levers the strengths of both organisations to provide strong local support for customers. ABN: 24 615 709 245 Email: sales@decodescience.com.au Contact: Joshua Warburton About Decode Science Decode Science is a privately owned Australian organisation specialising in the Life Science mark...

The bio-nanotechnology innovator Xing Technologies (hereinafter “XING”) is a UQ spin-off enterprise specialising in world-leading disease diagnosis and monitoring technologies, including cancer. Its proprietary nano-technologies are transforming the future practice of medicine and healthcare. BGI, a global genomics giant, is the largest organisation in the world in genomics research and applications. With its strong technological capabilities and expertise in gene sequencing and instrument de...